Oncology & Cancer

Four things you should know about HPV vaccinations

The human papillomavirus (HPV) vaccine has attracted attention in the past week for two contradictory reasons: the Japanese government has withdrawn its recommendation for the shot, while public health officials in the United ...

Oncology & Cancer

Fewer than three doses of cervical cancer vaccine effective

Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study ...

Oncology & Cancer

Cervical vaccine also protects against anal cancer risk

A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.

page 1 from 2

Cervarix

Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).

Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases. These types also cause some other genital cancers and some oropharyngeal cancers. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials. Cervarix also contains AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time.

Cervarix is manufactured by GlaxoSmithKline. An alternative product, from Merck & Co., is known as Gardasil.

This text uses material from Wikipedia, licensed under CC BY-SA